ISCHEMIC STROKE

Image

pRESET

ANEURYSM TREATMENT

ACCESS AND DELIVERY

TECHNOLOGIES

Image

HPC

Hydrophilic Polymer Coating

HPC is an aneurysm implant and Flow Diverter coating, which shall reduce the risk of thrombosis on the surface of stents. Due to the thrombogenic surface, platelet function-inhibiting drugs are needed to prevent in-stent thrombosis. The current solution of preventing platelet activation is the Dual Anti-Platelet Therapy (DAPT) consisting of Aspirin and Clopidogrel. HPC reduces the risk of thrombus formation on the implant by initially reducing or preventing the adhesion of platelets when in contact with blood. The whole implant is covered with an invisible coating.


For more information click here.

UPCOMING EVENTS

July

26Jul(Jul 26)0:0030(Jul 30)23:59SNIS 2021SNIS 18th Annual Meeting & Fellows CourseColorado Springs, CO, USA

September

01Sep0:0003(Sep 3)0:00ESOC 20217th European Stroke ConferenceHelsinki, Finland

08Sep(Sep 8)0:0010(Sep 10)23:59ESMINT 202113th 13th ESMINT CongressAcropolis Convention Centre - Nice, France

14Sep(Sep 14)0:0016(Sep 16)0:00LINNC Paris 2021LINNC Paris 2021 Course - Live Cases Onsite & OnlineCarrousel du Louvre - Paris, France

October

05Oct(Oct 5)8:0007(Oct 7)17:00SLICE Worldwide 2021SLICE Worldwide - Stroke Live CourseVirtual

06Oct(Oct 6)8:0008(Oct 8)17:30neuroRAD 202156. Jahrestagung der Deutschen Gesellschaft für Neuroradiologie e.V.Virtual

OUR TREATMENT SOLUTIONS

ANEURYSM TREATMENT

ISCHEMIC STROKE

ACCESS AND DELIVERY